清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

3:45 PM Abstract No. 376 Clear cell hepatocellular carcinoma is associated with non-viral cirrhosis and arterial-phase hypo-enhancement but does not predict outcome after locoregional therapy

医学 肝细胞癌 肝硬化 胃肠病学 比例危险模型 危险系数 经皮 活检 内科学 放射科 肿瘤科 置信区间
作者
B. Park,Ruchi Gaba,Yi Huang,Y. Chen,Gabriela Guzmán,R. Peter Lokken
出处
期刊:Journal of Vascular and Interventional Radiology [Elsevier BV]
卷期号:29 (4): S161-S161
标识
DOI:10.1016/j.jvir.2018.01.417
摘要

Clear cell hepatocellular carcinoma (HCC) is a less common HCC cytologic variant associated with improved outcomes in studies prior to the advent of locoregional therapy (LRT). This study was undertaken to determine whether clear cell HCC predicts better outcomes after LRT. We retrospectively identified 124 consecutive patients (92 men, 32 women; median age 59 y) with 132 HCC (mean diameter 4.8 ± 3.9 cm) diagnosed by percutaneous biopsy between 2008-2017 prior to transarterial chemoembolization (TACE) (n = 51, 41%), yttrium-90 radioembolization (n = 17, 13%), percutaneous thermal ablation (n = 41, 33%), and combination TACE/ablation (n = 15, 12%). Baseline Barcelona Clinic Liver Cancer (BCLC) stage was 0/A (n = 48, 38%), B (n = 33, 26%), C (n = 27, 22%), and D (n = 16, 13%). Cytological subtype was determined from percutaneous core needle biopsy as 100% clear cells, focal clear cells, or no clear cells. Baseline clinical and imaging features, and radiologic response by mRECIST were correlated with cytological subtype using multinomial regression analysis. Time to progression (TTP) and transplant free survival (TFS) were analyzed by Cox proportional hazard models. Percutaneous core biopsies comprised entirely of clear cell subtype were associated with non-viral etiologies of HCC (OR 5.3 95% CI 1.64-17.16; p = 0.005), solid histological arrangement (OR 4.32 95% CI 1.14-16.37; p = 0.031), and hypo-enhancement on arterial phase CT or MRI images (OR 3.08 95% CI 1.02-9.3; p = 0.046). The clear cell subtype was not associated with improved objective response by mRECIST (OR 0.93 95% CI 0.37-2.33; p = 0.87), delayed TTP (HR 1.17 95% CI 0.86-1.6; p = 0.32), or better TFS (HR 1.01 95% CI 0.69-1.47; p = 0.96) in comparison to specimens with focal or no clear cells. There remained no significant association between the clear cell subtype and TTP or TFS after stratifying by LRT modalities. Clear cell HCC is more common in non-viral etiologies of cirrhosis and is associated with atypical enhancement on radiologic images. It does not, however, impart independent prognostic information prior to LRT.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
简单完成签到 ,获得积分10
3秒前
温暖的大船完成签到,获得积分10
6秒前
兜有米完成签到 ,获得积分10
6秒前
酷波er的应助被顶刊相见采纳,获得10
8秒前
16秒前
16秒前
buqi完成签到,获得积分10
16秒前
Husile发布了新的文献求助10
20秒前
李思雨完成签到 ,获得积分10
22秒前
标致雁兰完成签到,获得积分10
30秒前
雪山飞龙发布了新的文献求助10
40秒前
40秒前
如意嫣完成签到,获得积分10
41秒前
郑丽琴完成签到 ,获得积分10
44秒前
Pluto完成签到 ,获得积分10
45秒前
46秒前
潇洒的老黑完成签到,获得积分10
46秒前
50秒前
朱洪帆完成签到,获得积分20
54秒前
回家放羊发布了新的文献求助10
55秒前
感动初蓝完成签到 ,获得积分10
56秒前
chenchen完成签到 ,获得积分10
1分钟前
1分钟前
迷路的穆完成签到,获得积分10
1分钟前
武雨寒完成签到,获得积分20
1分钟前
自然的妙梦完成签到,获得积分10
1分钟前
lulu发布了新的文献求助30
1分钟前
贪玩的机器猫完成签到 ,获得积分10
1分钟前
1分钟前
科研通AI6.3的应助被lCJ采纳,获得10
1分钟前
ZIYE的应助被lulu采纳,获得100
1分钟前
ubless607的应助被lulu采纳,获得10
1分钟前
打打的应助被lulu采纳,获得10
1分钟前
shilly完成签到 ,获得积分10
1分钟前
激情的盼晴完成签到,获得积分10
1分钟前
2分钟前
沉默怡完成签到,获得积分10
2分钟前
明亮的小兔子完成签到 ,获得积分10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179980
求助须知:如何正确求助?哪些是违规求助? 9570196
关于积分的说明 21808506
捐赠科研通 7775966
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557389
邀请新用户注册赠送积分活动 2478998